Population
Hepatitis A virus (HAV) full and empty particles
Design
Preclinical
Authors
Loading...
Does not support clinical translation; leaves open therapeutic development of capsid-destabilizing antibodies.
The R10 monoclonal antibody neutralizes HAV by blocking host cell attachment and destabilizing the capsid, suggesting a receptor mimic mechanism that could inform therapeutic development.
Wang et al. (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: